Article
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.
BMC infectious diseases - 21 Jul 2014
Frentz Dineke, Van de Vijver David A M C, Abecasis Ana B, Albert Jan, Hamouda Osamah, Jørgensen Louise B, Kücherer Claudia, Struck Daniel, Schmit Jean-Claude, Vercauteren Jurgen, Åsjö Birgitta, Balotta Claudia, Beshkov Danail, Camacho Ricardo J, Clotet Bonaventura, Coughlan Suzie, Griskevicius Algirdas, Grossman Zehava, Horban Andrzej, Kolupajeva Tatjana, Korn Klaus, Kostrikis Leondios G, Liitsola Kirsi, Linka Marek, Nielsen Claus, Otelea Dan, Paraskevis Dimitrios, Paredes Roger, Poljak Mario, Puchhammer-Stöckl Elisabeth, Sönnerborg Anders, Stanekova Danica, Stanojevic Maja, Van Wijngaerden Eric, Wensing Annemarie M J, Boucher Charles A B
Abstract excerpt
BACKGROUND: One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance mutations (TDRM) using data from the European Spread program. METHODS: Clinical, epidemiological and virological data from 4317 patients newly diagnosed with HIV-1 infection between 2002 and 2007 were analysed. Patients were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.